We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Diabetes & Endocrinology

Planetary Health and Plant-Based Diets: Reducing Type 2 Diabetes Risk in UK Adults

MedXY Editorial Team•Oct 20, 2025•Diabetes & Endocrinology
Planetary Health Diettype 2 diabetesUK Biobank

Highlight

  • Higher adherence to the Planetary Health Diet Index (PHDI) significantly lowers the risk of developing type 2 diabetes.
  • The PHDI’s protective effect is comparable or superior to several well-established plant-based diet scores, including the alternate Mediterranean Diet and DASH.
  • Vegetables, fish, reduced red/processed meats, and limited added sugars consumption drive reduced diabetes risk within these dietary patterns.
  • Body mass index (BMI) partially mediates but does not fully explain the relationship between PHDI adherence and diabetes risk.

Study Background

Type 2 diabetes mellitus (T2DM) remains a major contributor to global morbidity and mortality, characterized by insulin resistance and pancreatic beta-cell dysfunction leading to chronic hyperglycemia. The rising prevalence parallels lifestyle factors including diet quality, obesity, and sedentary behavior. Plant-based diets (PBDs), emphasizing whole plant foods and minimizing animal products, have garnered attention for their role in metabolic health and chronic disease prevention. Such diets also carry environmental sustainability benefits, aligning with planetary health goals.

The Planetary Health Diet Index (PHDI) operationalizes adherence to a diet designed for both human health and ecological sustainability, incorporating 14 food groups with specific consumption recommendations. Despite the theoretical advantages, epidemiologic evidence linking PHDI adherence to T2DM risk remains sparse, especially in large-scale prospective cohorts. The current study addresses this gap by evaluating the PHDI alongside other recognized PBDs such as the alternate Mediterranean Diet (aMED), healthful plant-based diet index (hPDI), Dietary Approaches to Stop Hypertension (DASH), and Alternate Healthy Eating Index (AHEI-2010).

Study Design

This prospective cohort study utilized data from 112,032 middle-aged adults (40-69 years) from the UK Biobank, all free of T2DM and cardiovascular disease at baseline (2009–2012). Dietary intake was assessed using at least two 24-hour dietary recalls per participant, capturing detailed food consumption.

Foods were categorized to compute PHDI scores (scale 0 to 130), reflecting adherence to the Planetary Health Diet recommendations across 14 food groups. Comparative diet scores (aMED, hPDI, DASH, AHEI-2010) were calculated using established methodologies.

Incident T2DM was ascertained through linked clinical data, including hospital records and self-reports, over a median 9.4-year follow-up until 2021. Cox proportional hazards regression models estimated hazard ratios (HRs) and 95% confidence intervals (CIs), adjusting for potential confounders such as age, sex, socioeconomic status, smoking, physical activity, and energy intake. BMI was further adjusted to assess its mediating effect.

Key Findings

During follow-up, 2,666 new T2DM cases were identified. Participants with the highest adherence to the PHDI (top quartile) demonstrated a 43% lower risk of developing T2DM compared to those in the lowest adherence quartile (multivariable-adjusted HR 0.57, 95% CI 0.50 to 0.64). This risk reduction was more pronounced than that observed for aMED (HR 0.70, 95% CI 0.62 to 0.78) and hPDI (HR 0.64, 95% CI 0.57 to 0.72), and comparable to DASH (HR 0.58, 95% CI 0.51 to 0.65) and AHEI-2010 (HR 0.59, 95% CI 0.53 to 0.67).

Adjusting for BMI attenuated these hazard ratios by 13-19%, indicating that while adiposity partially mediates the diet-diabetes association, other physiological pathways likely contribute. Key components associated with lower T2DM risk included high intake of vegetables and fish, and limiting red/processed meats and added sugars.

These findings underscore the metabolic benefits of dietary patterns that balance health and sustainability without compromising clinical efficacy when compared to established plant-based diets.

Expert Commentary

The large sample size, prospective design, and robust outcome ascertainment strengthen the reliability of these results. The use of repeated 24-hour dietary recalls enhanced exposure assessment precision, though some measurement error remains inevitable.

The partial attenuation upon BMI adjustment aligns with the established role of obesity as a diabetes risk factor, also suggesting that the PHDI may influence diabetes risk via improved insulin sensitivity, reduced inflammation, or modulation of gut microbiota.

Given the comparability with other validated diet scores, the PHDI offers an attractive framework integrating nutritional and planetary concerns. However, generalizability may be limited to similar middle-aged European populations, and residual confounding cannot be excluded.

Future studies should explore mechanistic pathways and assess intervention feasibility and long-term adherence in diverse settings.

Conclusion

This UK Biobank prospective analysis establishes that higher adherence to the Planetary Health Diet Index is robustly associated with reduced risk of type 2 diabetes, with effect sizes comparable to or greater than other renowned plant-based dietary indices. The results support dietary recommendations that harmonize human metabolic health with environmental sustainability, suggesting that promotion of the PHDI might constitute an effective public health strategy to curb the growing diabetes epidemic.

Further research is warranted to clarify biological mechanisms and to implement sustainable dietary interventions at the population level.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Fenofibrate Use and Reduced Risk of Sight-Threatening Diabetic Retinopathy in Type 2 Diabetes: Insights from UK Real-World DataFenofibrate use in type 2 diabetes patients is associated with a significant reduction in the risk of sight-threatening diabetic retinopathy compared to statins, based on UK primary care data over 12 years.Sep 18, 2026Differential Gastrointestinal Risks of Opioids in Type 2 Diabetes Patients on GLP-1RA Therapy: A Comparative AnalysisAmong type 2 diabetes patients using GLP-1 receptor agonists, oxycodone is linked to higher short-term risks of severe gastrointestinal complications compared to hydrocodone and tramadol, warranting cautious opioid selection in this populatSep 15, 2026Common Anti-Inflammatory Drugs Linked to Lower Risk of Vision-Threatening Diabetic Retinopathy in Type 2 DiabetesA large retrospective cohort study suggests that cetirizine, ibuprofen, and prednisone use in adults with type 2 diabetes is associated with significantly reduced incidence of diabetic macular edema and proliferative diabetic retinopathy, hSep 15, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Linking Female Infertility History to Type 2 Diabetes Risk: Insights from the Nurses’ Health Study II
This study explores the increased risk of type 2 diabetes among women with a history of infertility, highlighting specific infertility causes and implications independent of BMI.
Sep 6, 2026
Sarcopenic Obesity and Type 2 Diabetes Risk: Insights from the UK Biobank StudyThis study reveals sarcopenic obesity significantly increases the risk of incident type 2 diabetes, exceeding risks from obesity or sarcopenia alone, highlighting the importance of combined muscle and adiposity assessment in diabetes prevenSep 6, 2026
Decoding Pancreatic Islet Single-Cell Transcriptomic Diversity Across Type 2 Diabetes SubtypesSingle-cell RNA sequencing of pancreatic islets reveals distinct molecular signatures linked to specific clinical subtypes of type 2 diabetes, highlighting the heterogeneous pathophysiology and providing potential subtype-specific therapeutSep 5, 2026